Abstract
The reduction in the frequency of rejection episodes several months after heart transplantation (HTX) correlates with the development of donor-specific nonresponsiveness. This is reflected in a reduced frequency of donor-specific cytotoxic T cells (CTL) in the peripheral blood. We investigated whether the reduced CTL frequency and the incidence of rejection episodes coincided with a change in the frequency of either IL-2- or IL-4-producing helper T lymphocytes (HTL). We measured the frequency of HTL before and at several time points after HTX in the blood of ten recipients, using limiting dilution analysis for IL-2 and IL-4. In most patients, HTL frequencies dropped immediately after transplantation, but returned to pre-HTX values later after transplantation. No consistent decrease or increase in frequencies was observed long after HTX. In contrast to IL-2, the HTL frequencies for IL-4 before transplantation were significantly higher in patients without post-HTX rejection episodes requiring treatment than in patients with such episodes. This phenomenon was observed for the in vitro responses towards both donor and third-party cells. In conclusion, relatively high frequencies of IL-4-producing T cells may have a beneficial effect on the outcome of human heart transplantation, because they are associated with a reduced incidence of rejection episodes after transplantation.
Original language | English |
---|---|
Pages (from-to) | S216-S224 |
Number of pages | 9 |
Journal | Transplant International |
Volume | 13 |
Issue number | (Suppl 1) |
Publication status | Published - 2000 |
Keywords
- Biomarkers
- Graft Rejection
- HLA-A Antigens
- HLA-B Antigens
- HLA-DR Antigens
- Heart Transplantation
- Histocompatibility Testing
- Humans
- Incidence
- Interleukin-2
- Interleukin-4
- T-Lymphocytes, Cytotoxic
- T-Lymphocytes, Helper-Inducer
- Time Factors
- Tissue Donors
- Transplantation, Homologous